565 related articles for article (PubMed ID: 30057282)
1. Polysaccharides as vaccine adjuvants.
Sun B; Yu S; Zhao D; Guo S; Wang X; Zhao K
Vaccine; 2018 Aug; 36(35):5226-5234. PubMed ID: 30057282
[TBL] [Abstract][Full Text] [Related]
2. Polysaccharides derived from Chinese medicinal herbs: A promising choice of vaccine adjuvants.
Wan X; Yin Y; Zhou C; Hou L; Cui Q; Zhang X; Cai X; Wang Y; Wang L; Tian J
Carbohydr Polym; 2022 Jan; 276():118739. PubMed ID: 34823775
[TBL] [Abstract][Full Text] [Related]
3. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
[TBL] [Abstract][Full Text] [Related]
4. Adjuvants in veterinary vaccines: modes of action and adverse effects.
Spickler AR; Roth JA
J Vet Intern Med; 2003; 17(3):273-81. PubMed ID: 12774966
[TBL] [Abstract][Full Text] [Related]
5. Nanoengineering of vaccines using natural polysaccharides.
Cordeiro AS; Alonso MJ; de la Fuente M
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1279-93. PubMed ID: 26049133
[TBL] [Abstract][Full Text] [Related]
6. Immunostimulatory effect of chitosan and quaternary chitosan: A review of potential vaccine adjuvants.
Li X; Xing R; Xu C; Liu S; Qin Y; Li K; Yu H; Li P
Carbohydr Polym; 2021 Jul; 264():118050. PubMed ID: 33910752
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate-containing nanoparticles as vaccine adjuvants.
Zhang X; Zhang Z; Xia N; Zhao Q
Expert Rev Vaccines; 2021 Jul; 20(7):797-810. PubMed ID: 34101528
[No Abstract] [Full Text] [Related]
8. The impact of size on particulate vaccine adjuvants.
Shah RR; O'Hagan DT; Amiji MM; Brito LA
Nanomedicine (Lond); 2014 Dec; 9(17):2671-81. PubMed ID: 25529570
[TBL] [Abstract][Full Text] [Related]
9. Polysaccharides: Candidates of promising vaccine adjuvants.
Li P; Wang F
Drug Discov Ther; 2015 Apr; 9(2):88-93. PubMed ID: 25994059
[TBL] [Abstract][Full Text] [Related]
10. Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.
Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; El-Baky NA; Redwan EM
Hum Antibodies; 2018 Feb; 26(2):75-85. PubMed ID: 29171990
[TBL] [Abstract][Full Text] [Related]
11. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
12. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization.
Wei J; Xue W; Yu X; Qiu X; Liu Z
J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory properties of chitosan polymers.
Moran HBT; Turley JL; Andersson M; Lavelle EC
Biomaterials; 2018 Nov; 184():1-9. PubMed ID: 30195140
[TBL] [Abstract][Full Text] [Related]
14. Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.
Zaharoff DA; Rogers CJ; Hance KW; Schlom J; Greiner JW
Vaccine; 2007 Mar; 25(11):2085-94. PubMed ID: 17258843
[TBL] [Abstract][Full Text] [Related]
15. Association of chitosan and aluminium as a new adjuvant strategy for improved vaccination.
Lebre F; Bento D; Ribeiro J; Colaço M; Borchard G; de Lima MCP; Borges O
Int J Pharm; 2017 Jul; 527(1-2):103-114. PubMed ID: 28522427
[TBL] [Abstract][Full Text] [Related]
16. Adjuvants for human vaccines--current status, problems and future prospects.
Gupta RK; Siber GR
Vaccine; 1995 Oct; 13(14):1263-76. PubMed ID: 8585280
[TBL] [Abstract][Full Text] [Related]
17. An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.
Chauhan N; Tiwari S; Iype T; Jain U
Expert Rev Vaccines; 2017 May; 16(5):491-502. PubMed ID: 28285554
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
Bento D; Staats HF; Gonçalves T; Borges O
Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
[TBL] [Abstract][Full Text] [Related]
19. Effect of different adjuvant formulations on the immunogenicity and protective effect of a live Mycoplasma hyopneumoniae vaccine after intramuscular inoculation.
Xiong Q; Wei Y; Xie H; Feng Z; Gan Y; Wang C; Liu M; Bai F; Xie F; Shao G
Vaccine; 2014 Jun; 32(27):3445-51. PubMed ID: 24731810
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvants of influenza vaccines: new possibilities of using sulphated polysaccharides from marine brown algae.].
Kuznetsova TA; Persiyanova EV; Zaporozhets TS; Besednova NN
Vopr Virusol; 2019; 64(1):5-11. PubMed ID: 30893523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
